Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma

被引:29
|
作者
Zhan, Zhu [1 ,2 ,3 ]
Guan, Yalan [1 ,2 ,3 ]
Mew, Kenley [4 ]
Zeng, Weigiong [1 ,2 ,3 ]
Peng, Mingli [1 ,2 ,3 ]
Hu, Peng [1 ,2 ,3 ]
Yang, Yixuan [1 ,2 ,3 ]
Lu, Yi [1 ,2 ,3 ]
Ren, Hong [1 ,2 ,3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China
[2] Chongqing Med Univ, Inst Viral Hepatitis, Chongqing, Peoples R China
[3] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China
[4] Chongqing Med Univ, Dept Foreign Language, Chongqing, Peoples R China
关键词
biomarker; hepatocellular carcinoma; proteomic; urine; alpha-fetoprotein; CLINICAL-PRACTICE GUIDELINES; ALPHA-1-ACID GLYCOPROTEIN; PROTEIN; COMBINATION; MANAGEMENT;
D O I
10.1152/ajpgi.00267.2019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the sixth common malignant tumor worldwide. but current efficient and convenient screening methods remain lacking. This study aimed to discover a diagnostic or a screening biomarker from the urine of hepatitis B virus (HBV)-related HCC patients. We used iTRAQ coupled with mass spectrometry to identify candidate urinary proteins in a discovery cohort (n = 40). The selected proteins were confirmed using ELISA in a validation cohort (n = 140). Diagnostic performance of the selected proteins was assessed using receiver operating characteristic (ROC) and qualitative diagnostic analysis. A total of 96 differentially expressed proteins were identified. Urinary alpha-fetoprotein (u-AFP) and orosomucoid 1 (u-ORM1) were selected as target proteins by bioinformatics analysis and were significantly higher in HCC than in non-HCC patients, as validated by Western blot analysis and ELISA. u-AFP had a strong correlation with serum AFP-L3 (Pearson's r = 0.944, P < 0.0001), indicating that u-AFP may be derived from circulating blood. The area under the curve (AUC) of u-AFP was 0.795 with a sensitivity of 62.5% and a specificity of 95.4%, which showed no significantly difference with scrum AFP (se-AFP). The AUC was 0.864 as u-AFP and u-ORM1 were combined, and they performed much better than u-AFP or u-ORM1 alone. Qualitative diagnostic analysis showed that the positive predictive value of u-AFP was 90.1% and the diagnostic sensitivity of parallel combination of u-AFP and u-ORM1 was 85.1%. Taken together, AFP and ORM1 in the urine may be used as a diagnostic or screening biomarker of HCC, and studies on large samples are needed to validate the result. NEW & NOTEWORTHY This study provides a novel way to find biomarkers of hepatocellular carcinoma (HCC) and a new perspective of alpha-fetoprotein clinical application. The urine reagent strips may be helpful in high epidemic areas of HCC and in low-resource settings.
引用
收藏
页码:G305 / G312
页数:8
相关论文
共 50 条
  • [1] Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Rizzo, Giacomo Emanuele Maria
    Cabibbo, Giuseppe
    Craxi, Antonio
    VIRUSES-BASEL, 2022, 14 (05):
  • [2] Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Xie, Youhua
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 11 - 21
  • [3] Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
    Stijn Van Hees
    Peter Michielsen
    Thomas Vanwolleghem
    World Journal of Gastroenterology, 2016, (37) : 8271 - 8282
  • [4] Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
    Van Hees, Stijn
    Michielsen, Peter
    Vanwolleghem, Thomas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8271 - 8282
  • [5] Pathogenesis of hepatitis B virus-associated hepatocellular carcinoma
    Tabor, Edward
    HEPATOLOGY RESEARCH, 2007, 37 : S110 - S114
  • [6] Diagnostic value of PIVKA-Ⅱ and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma
    Seung In Seo
    Hyoung Su Kim
    Won Jin Kim
    Woon Geon Shin
    Doo Jin Kim
    Kyung Ho Kim
    Myoung Kuk Jang
    Jin Heon Lee
    Joo Seop Kim
    Hak Yang Kim
    Dong Joon Kim
    Myung Seok Lee
    Choong Kee Park
    World Journal of Gastroenterology, 2015, 21 (13) : 3928 - 3935
  • [7] A prediction nomogram for hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yijin
    Wan, Gang
    Li, Hongjie
    Gao, Lili
    Liu, Nan
    Gao, Ping
    Liu, Yaping
    Gao, Xuesong
    Duan, Xuefei
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (01) : 70 - 77
  • [8] Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma
    Huang, Jian
    Deng, Qing
    Wang, Qun
    Li, Kun-Yu
    Dai, Ji-Hong
    Li, Niu
    Zhu, Zhi-Dong
    Zhou, Bo
    Liu, Xiao-Yan
    Liu, Rui-Fang
    Fei, Qian-Lan
    Chen, Hui
    Cai, Bing
    Zhou, Boping
    Xiao, Hua-Sheng
    Qin, Lun-Xiu
    Han, Ze-Guang
    NATURE GENETICS, 2012, 44 (10) : 1117 - +
  • [9] Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma
    Jiaoxia He
    Zhongling Zheng
    Tingting Liu
    Yupei Ao
    Yixuan Yang
    Huaidong Hu
    Scientific Reports, 12
  • [10] Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma
    He, Jiaoxia
    Zheng, Zhongling
    Liu, Tingting
    Ao, Yupei
    Yang, Yixuan
    Hu, Huaidong
    SCIENTIFIC REPORTS, 2022, 12 (01)